[Sequence treatment of postmenopausal osteoporosis].

Initial therapy for low-risk patients typically involves potent antiresorptive agents such as bisphosphonates or denosumab to reduce bone resorption and fracture risk. For high-risk patients, bone anabolic agents like teriparatide or romosozumab may…

Preview only. Read the full abstract at the source